1. Should you try Woebot? Overview

What it is	Woebot is a clinically validated CBT chatbot that pivoted in 2025 from a consumer app to an enterprise-only platform distributed by health systems, payers and employers.
Country / HQ	San Francisco, California, USA (Woebot Health, founded 2017 by clinical psychologist Alison Darcy)
Best for	Health systems, payers and employers offering evidence-based digital mental health at population scale.
Check before buying	The direct-to-consumer app shut down June 30, 2025 – individuals now need an access code from a partner organization.
Editor rating	4.2 / 5
Pricing signal	Free — no paid tier

2. Features What it does

Feature	What it does
CBT-based relational agent	Scripted, clinically written conversations (not generative AI).
Mood tracking	Check-ins with progress reflection over weeks.
Crisis language detection	Flags concerning language and surfaces crisis resources.
WB001 postpartum program	FDA Breakthrough Device designation for postpartum depression.
Population health tools	Access Accelerator modules for limited clinician capacity.
Open Access API	Embed Woebot conversations in third-party health apps.
Evidence base	15+ randomized controlled trials backing effect sizes.

Plan	Price / mo	Key limits & who it fits
Enterprise (PMPM)	Custom	Per-member-per-month contracts with payers, providers and employers.
Per treatment cycle	$200-$450 (cited)	Reported per-cycle fees for specific programs.
Consumer app	Discontinued	The old consumer subscription ended June 2025.

Fully B2B pricing – not published. Tool directories still citing consumer tiers are out of date. Contact Woebot Health for partner terms.

Access type	Details
Platform	iOS, Android via partner access codes.
Health systems	EMR/EHR-adjacent workflows and partner portals.
Compliance	HIPAA, GDPR, SOC 2 Type II.
API	2025 Open Access API for embedding.

Source	Rating	What it says
Clinical literature	Positive	RCTs show meaningful symptom reduction for anxiety and depression.
IntuitionLabs profile	4.3 / 5	Enterprise pivot praised for clinical rigor; consumer shutdown noted.
Former app users	Mixed	Loved the experience; disappointed by the 2025 consumer exit.

✔ Suitable	✘ Not suitable
• Health plans and systems scaling behavioral health • Maternal health and adolescent programs • Employers adding evidence-based benefits	• Individual consumers without a partner access code • Users wanting freeform generative-AI chat • Organizations seeking off-the-shelf consumer apps

Competitor	How it differs	Best for
Wysa	Wysa keeps a consumer product plus B2B; Woebot is purely enterprise now.	Consumer + enterprise coverage.
Lyra/Modern Health	Full-service EAP platforms with human networks.	Comprehensive benefits.
Youper	Youper sells direct to consumers with AI conversations.	Self-serve mood support.

Takeaway	Clinically the gold standard of CBT chatbots, but as of mid-2025 you reach it through your health plan or employer – not the app store.
Who should pick it	Payers, providers and employers that want RCT-backed digital mental health.
Who should skip it	Individuals expecting to download and subscribe directly.